Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation (Q39683623)

14 September 2017

title

Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation (English)

1 reference

14 September 2017

George Agelis

1 reference

14 September 2017

Amalia Resvani

1 reference

14 September 2017

Minos-Timotheos Matsoukas

1 reference

14 September 2017

Theodore Tselios

1 reference

14 September 2017

Konstantinos Kelaidonis

1 reference

14 September 2017

Dimitra Kalavrizioti

1 reference

14 September 2017

Demetrios Vlahakos

1 reference

14 September 2017

John Matsoukas

1 reference

14 September 2017

publication date

6 July 2010

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

411-420

1 reference

Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Aliskiren: an oral renin inhibitor for the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Recent developments in the design of angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

Proposal of a New Binding Orientation for Non-Peptide AT1 Antagonists: Homology Modeling, Docking and Three-Dimensional Quantitative Structure−Activity Relationship Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0651-Y

10.1007/S00726-010-0651-Y

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference